海外の治験の状況「1」での検索結果
544件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer
- Pancreatic Cancer
- Australia, Austria, Belgium, Canada, France, Germany, Ireland, Italy, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom, United States
- 2016-09-30
Recruiting
- RESIST-2: 2nd-line ART for HIV-2 Infection
- HIV-2 Infection
- Senegal
- 2017-12-14
Recruiting
- A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as First Line Treatment in Patients With Advanced Esophageal Squamous Cell Carcinoma
- Esophageal Squamous Cell Carcinoma (ESCC)
- Australia, Belgium, China, Czechia, France, Germany, Italy, Japan, Korea, Republic of, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2018-12-18
Recruiting
- Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)
- Advanced Melanoma
- Australia, Canada, Spain, Sweden, United States
- 2018-12-13
Recruiting
- A Study of GDC-9545 in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer
- Breast Cancer
- Australia, France, Germany, Spain, United Kingdom, United States
- 2019-04-10
Recruiting
- Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy
- Non-Small-Cell Lung
- Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Jordan, Korea, Republic of, Lebanon, Netherlands, Poland, Russian Federation, Singapore, Spain, Taiwan, United States
- 2018-07-25
Recruiting
- Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies
- Malaria
- Burkina Faso
- 2020-01-21
Recruiting
- An open-label, treatment-option protocol of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma, systemic anaplastic large cell lymphoma, or CD30-positive cutaneous T-cell lymphoma
- Australia, Belgium, Bulgaria, France, Germany, Hungary, Italy, Poland, Romania, Russian Federation, Serbia, Spain, Switzerland, United Kingdom, United States
- 2016-03-08
Recruiting
- Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)
- Charcot-Marie-Tooth Disease
- Australia, Italy, United States
- 2016-11-29
Recruiting
- A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Subjects With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody
- Multiple Myeloma
- Australia, Canada, France, Germany, Italy, Spain, United Kingdom, United States
- 2018-05-03